SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
14-Jul-23 4:00 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 13-Jul-23 | Sale | 5,344 | $0.70 | $3,740.80 | (< 1%) 9.16M to 9.15M | |
14-Jul-23 4:00 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 12-Jul-23 | Sale | 80,528 | $0.71 | $57,029.90 | (< 1%) 9.24M to 9.16M | |
26-Jun-23 4:46 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 23-Jun-23 | Sale | 18,100 | $0.70 | $12,735.20 | (< 1%) 9.26M to 9.24M | |
26-Jun-23 4:46 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 22-Jun-23 | Sale | 10,508 | $0.70 | $7,383.97 | (< 1%) 9.27M to 9.26M | |
22-Jun-23 4:00 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 21-Jun-23 | Sale | 138,962 | $0.70 | $97,634.70 | (1%) 9.41M to 9.27M | |
22-Jun-23 4:00 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 20-Jun-23 | Sale | 295,653 | $0.71 | $210,209.00 | (3%) 9.7M to 9.41M | |
08-Mar-23 7:38 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 06-Mar-23 | Acquisition (other) | 251,296 | -- | -- | 3% 9.45M to 9.7M | |
08-Dec-21 4:05 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 23-Nov-21 | Market Purchase | 42,518 | $12.44 | $529,102.00 | < 1% 9.43M to 9.47M | 16% |
15-May-18 12:39 PM View: | Avexis, Inc. (AVXS) | 15-May-18 | Disposition | 1,667 | -- | -- | (100%) 1.67K to 0 | |
27-Mar-18 5:34 PM View: | Avexis, Inc. (AVXS) | 13-Mar-18 | Grant | 1,667 | -- | -- | 100% 0 to 1.67K |